The Ethnopharmacological and Nutraceutical Relevance of Launaea taraxacifolia (Willd.) Amin ex C. Jeffrey

Table 3

A summary of reported pharmacological activities of Launaea taraxacifolia.

Study Model	Activity	IC50/Effective dosage	Preparation	Reference
In vitro	Antioxidant	DPPH(16.18μg/m); OH (128.2 μg/ml); NO (123.3 μg/ml))	Methanolic	[24]
In vivo	Antioxidant	400mg/kg bwt	Ethanolic	[25]
In vitro	Antioxidant	DPPH(6.59mg/ml); OH (1.94mg/ml); NO (12.8mg/ml)	Aqueous	[26]
		DPPH(3.29mg/ml); OH (2.46mg/ml); NO (4.88mg/ml)	Ethanolic	[26]
In vitro	Lipid peroxidation	23μg/ml	Methanolic	[24]
In vitro	Hypolipidaemic	20 μg/μl	Ethanol-aqueous	[27]
In vivo	Hypolipidaemic	Cholesterol (500mg/kg); TAG (500mg/kg)	Ethanol-aqueous	[28]
In vivo	Gentamicin protective effect	300, 500mg/kg	Ethanol-aqueous	[29]
In vitro	HepG2 cell viability	20μg/μl	Ethanol-aqueous	[27]
In vivo	Neuroprotective	400mg/kg	Ethanolic	[25]
In vitro	Anti-cancer	-	Aqueous	[30]
In vivo	Anti-cisplatin damage	100, 400mg/kg	Aqueous	[31, 32]
In vitro	Anti-arthritic	0.25mg/ml	Methanolic	[22]
In vitro	Anti-bacteria	250,500,1000μg/ml	Methanolic	[22]
In vitro	Antibacteria	1mg/ml	Methanol-dichloromethane	[23]
In vitro	DNA damage protection	20mg/ml	Methanolic	[24]
In vivo	Anti-malaria	200mg/kg	Methanolic	[33]
In vitro	Anti-malaria	21.55μg/μl	Chloroform	[34]
In vivo	Cardioprotective	200mg/kg	Aqueous	[46]